Cited by 73DNA and Nucleic Acid ChemistryTelomeres, Telomerase, and SenescenceAutophagy in Disease and Therapy

Modulation of the ATM/autophagy pathway by a G-quadruplex ligand tips the balance between senescence and apoptosis in cancer cells

Open access
Beauvarlet, Jennifer, Bensadoun, Paul, Darbo, Elodie, Labrunie, Gaelle, Rousseau, Benoît, Richard, Elodie, Draskovic, Irena, Londono-Vallejo, Arturo +11 more·2019·Nucleic Acids Research

Abstract

G-quadruplex ligands exert their antiproliferative effects through telomere-dependent and telomere-independent mechanisms, but the inter-relationships among autophagy, cell growth arrest and cell death induced by these ligands remain largely unexplored. Here, we demonstrate that the G-quadruplex ligand 20A causes growth arrest of cancer cells in culture and in a HeLa cell xenografted mouse model. This response is associated with the induction of senescence and apoptosis. Transcriptomic analysis of 20A treated cells reveals a significant functional enrichment of biological pathways related to growth arrest, DNA damage response and the lysosomal pathway. 20A elicits global DNA damage but not telomeric damage and activates the ATM and autophagy pathways. Loss of ATM following 20A treatment inhibits both autophagy and senescence and sensitizes cells to death. Moreover, disruption of autophagy by deletion of two essential autophagy genes ATG5 and ATG7 leads to failure of CHK1 activation by 20A and subsequently increased cell death. Our results, therefore, identify the activation of ATM by 20A as a critical player in the balance between senescence and apoptosis and autophagy as one of the key mediators of such regulation. Thus, targeting the ATM/autophagy pathway might be a promising strategy to achieve the maximal anticancer effect of this compound.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkz095

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cellular treatment with G4 ligands, such as PDS or 20A, is linked to anti-tumorigenic effects and G2/M cell cycle arrest.

    “One study has linked cellular treatment with G4 ligands, such as PDS or 20A, to anti-tumorigenic effects and G2/M cell cycle arrest (71).”

    From G-quadruplex-mediated genomic instability drives SNVs in cancer (2024) · cites this paper as [71]

    The Discussion reports that the G4 ligand 20A inhibits cancer-cell growth in vitro and in vivo, supporting the anti-tumorigenic part of the claim. The Results describe growth arrest through senescence and apoptosis, but do not identify it as G2/M arrest; the passages found also do not establish the claimed effect for PDS (searched: G2/M, PDS/pyridostatin, and cell-cycle arrest). (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Beauvarlet, J., Bensadoun, P., Darbo, E., Labrunie, G., Rousseau, B., Richard, E., Draskovic, I., Londono-Vallejo, A., Dupuy, J.-W., Nath Das, R., Guédin, A., Robert, G., Orange, F., Croce, S., Valesco, V., Soubeyran, P., Ryan, K. M., Mergny, J.-L., & Djavaheri-Mergny, M.
Affiliations
  • Université de Bordeaux (FR)
  • Institut Bergonié, Université de Bordeaux, INSERM U1218, F-33076 Bordeaux, France
  • Service commun des animaleries, Université de Bordeaux, F-33000 Bordeaux, France
  • Institut Curie, PSL Research University, CNRS, UMR3244, F-75005 Paris, France
  • ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, IECB, F-33600, Pessac, France
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
  • Université Côte d’Azur, Centre Commun de Microscopie Appliquée (CCMA), 06108 Nice, France
  • Institut Bergonié (FR)
  • Department of Biopathology, Institut Bergonié, F-33076 Bordeaux, France
  • Cancer Research UK Scotland Institute (GB)
Corresponding author
Mergny, Jean-Louis
Venue
Nucleic Acids Research
Published
2019-02-13
Volume
47
Issue
6
Pages
2739-2756
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2913579109
Cited by
73
References
80
Citations by year
2026: 5 · 2025: 6 · 2024: 11 · 2023: 6 · 2022: 8 · 2021: 20 · 2020: 13 · 2019: 4
FWCI
3.72
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • HAL (submittedVersion, other-oa)
  • HAL (submittedVersion)
Funders
SYMBIT project (CZ.02.1.01/0.0/0.0/15_003/0000477)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
G-quadruplex ligands, ATM, autophagy, cellular senescence, apoptosis, cancer cells, growth arrest, DNA damage response, lysosomal pathway, Chk1 activation, ATG5, ATG7, anticancer drug synergy
MeSH terms
A549 Cells, Animals, Autophagy, DNA Damage, HeLa Cells, Humans, Ligands, Male, Neoplasms, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Cellular Senescence, Apoptosis, Mice, Knockout, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, G-Quadruplexes, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review